William Pickering's Stock Ratings

Bernstein Analyst

William Pickering is an analyst at Bernstein. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

-2.77%

Smart Score

45.4%

Overall Average Return Percentile

28th

Number of Ratings

31
Buy NowGet Alert
12/11/2025BBIOBuy Now
BridgeBio Pharma
$75.2025% → $94Initiates → OutperformGet Alert
11/06/2025BHVNBuy Now
Biohaven
$11.43-21.26%$34 → $9DowngradeOutperform → Market PerformGet Alert
11/03/2025BIIBBuy Now
Biogen
$174.15-9.85%$155 → $157MaintainsMarket PerformGet Alert
11/03/2025BMRNBuy Now
BioMarin Pharmaceutical
$52.3967.97%$95 → $88MaintainsOutperformGet Alert
10/28/2025NTLABuy Now
Intellia Therapeutics
$9.0859.69%$14 → $14.5DowngradeOutperform → Market PerformGet Alert
10/27/2025RNABuy Now
Avidity Biosciences
$71.890.15%$52 → $72DowngradeOutperform → Market PerformGet Alert
08/27/2025REGNBuy Now
Regeneron Pharmaceuticals
$753.753.61%$753 → $781MaintainsOutperformGet Alert
07/29/2025SRPTBuy Now
Sarepta Therapeutics
$21.28-38.91% → $13Initiates → Market PerformGet Alert
01/07/2025ALNYBuy Now
Alnylam Pharmaceuticals
$398.33-22.18%$314 → $310MaintainsOutperformGet Alert
01/07/2025REGNBuy Now
Regeneron Pharmaceuticals
$753.7541.96%$1110 → $1070MaintainsOutperformGet Alert
11/29/2024ARWRBuy Now
Arrowhead Pharma
$68.99-65.21%$27 → $24MaintainsMarket PerformGet Alert
09/24/2024BHVNBuy Now
Biohaven
$11.43477.43%$55 → $66MaintainsOutperformGet Alert
09/17/2024BMRNBuy Now
Biomarin Pharmaceutical
$52.3971.79%$116 → $90MaintainsOutperformGet Alert
09/04/2024BHVNBuy Now
Biohaven
$11.43381.19% → $55Initiates → OutperformGet Alert
08/20/2024BMRNBuy Now
Biomarin Pharmaceutical
$52.39109.96%$94 → $110UpgradeMarket Perform → OutperformGet Alert
06/14/2024IONSBuy Now
Ionis Pharmaceuticals
$80.68——UpgradeUnderperform → Market PerformGet Alert
03/12/2024REGNBuy Now
Regeneron Pharmaceuticals
$753.7549.25% → $1125Initiates → OutperformGet Alert
02/02/2024VRTXBuy Now
Vertex Pharmaceuticals
$450.72——DowngradeOutperform → Market PerformGet Alert
10/23/2023BMRNBuy Now
Biomarin Pharmaceutical
$52.3956.52% → $82UpgradeUnderperform → Market PerformGet Alert
08/02/2023VRTXBuy Now
Vertex Pharmaceuticals
$450.72-13.47%$380 → $390MaintainsOutperformGet Alert
07/28/2023VRTXBuy Now
Vertex Pharmaceuticals
$450.72-15.69% → $380MaintainsOutperformGet Alert
05/03/2023VRTXBuy Now
Vertex Pharmaceuticals
$450.72-19.46%$344 → $363MaintainsOutperformGet Alert
03/21/2023VRTXBuy Now
Vertex Pharmaceuticals
$450.72-23.68% → $344Initiates → OutperformGet Alert
03/21/2023BMRNBuy Now
Biomarin Pharmaceutical
$52.3954.61% → $81Initiates → UnderperformGet Alert
03/21/2023ALNYBuy Now
Alnylam Pharmaceuticals
$398.33-39% → $243Initiates → OutperformGet Alert
03/21/2023NTLABuy Now
Intellia Therapeutics
$9.08494.71% → $54Initiates → OutperformGet Alert
03/21/2023BEAMBuy Now
Beam Therapeutics
$27.6034.06% → $37Initiates → Market PerformGet Alert
03/21/2023ALLOBuy Now
Allogene Therapeutics
$1.48306.78% → $6Initiates → Market PerformGet Alert
03/21/2023CRSPBuy Now
CRISPR Therapeutics
$57.11-22.96% → $44Initiates → Market PerformGet Alert
03/21/2023ARWRBuy Now
Arrowhead Pharma
$68.99-60.86% → $27Initiates → Market PerformGet Alert
03/21/2023IONSBuy Now
Ionis Pharmaceuticals
$80.68-61.58% → $31Initiates → UnderperformGet Alert